US 11654145
Combination therapy involving diaryl macrocyclic compounds
granted A61KA61K31/517A61K31/519
Quick answer
US patent 11654145 (Combination therapy involving diaryl macrocyclic compounds) held by TURNING POINT THERAPEUTICS, INC. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TURNING POINT THERAPEUTICS, INC.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/517, A61K31/519, A61K45/06, A61P